investorscraft@gmail.com

Intrinsic Value of AVEO Pharmaceuticals, Inc. (AVEO)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %602.7NaN
Revenue, $42NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m92NaN
Operating income, $m-50NaN
EBITDA, $m-49NaN
Interest expense (income), $mNaN
Earnings before tax, $m-53NaN
Tax expense, $m0NaN
Net income, $m-53NaN

BALANCE SHEET

Cash and short-term investments, $m87NaN
Total assets, $m105NaN
Adjusted assets (=assets-cash), $m18NaN
Average production assets, $m265NaN
Working capital, $m86NaN
Total debt, $m38NaN
Total liabilities, $m59NaN
Total equity, $m46NaN
Debt-to-equity ratio0.828NaN
Adjusted equity ratio-2.301NaN

CASH FLOW

Net income, $m-53NaN
Depreciation, amort., depletion, $m0NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-57NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m0NaN
Free cash flow, $m-57NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m86
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount